Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Gili Halfteck

Concepts (60)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
3
2024
1198
0.670
Why?
Gallbladder Neoplasms
1
2019
7
0.630
Why?
Adenoma
1
2019
113
0.570
Why?
Adenocarcinoma
1
2019
396
0.470
Why?
Neoplasm Invasiveness
2
2024
269
0.360
Why?
Natural Cytotoxicity Triggering Receptor 1
1
2009
4
0.320
Why?
Antigens, Ly
1
2009
9
0.310
Why?
Cytotoxicity, Immunologic
1
2009
57
0.310
Why?
Killer Cells, Natural
1
2009
107
0.300
Why?
Lymphoma
1
2009
66
0.290
Why?
Laparoscopy
2
2022
172
0.270
Why?
Mastectomy
2
2023
142
0.240
Why?
Retrospective Studies
6
2024
6274
0.240
Why?
Parathyroid Neoplasms
1
2024
28
0.220
Why?
Neoplasm Staging
2
2024
738
0.220
Why?
Axilla
1
2024
92
0.220
Why?
Neoplasm Recurrence, Local
3
2024
622
0.220
Why?
Sentinel Lymph Node Biopsy
1
2024
118
0.210
Why?
Radiotherapy, Adjuvant
1
2023
63
0.210
Why?
Lymph Node Excision
1
2024
131
0.210
Why?
Neoadjuvant Therapy
1
2024
119
0.210
Why?
Intestinal Fistula
1
2022
9
0.200
Why?
Mammaplasty
1
2022
44
0.190
Why?
Lymph Nodes
1
2023
256
0.180
Why?
Crohn Disease
1
2022
93
0.180
Why?
Prospective Studies
1
2023
2378
0.140
Why?
Infant, Newborn
1
2023
2752
0.130
Why?
Cushing Syndrome
1
2014
10
0.120
Why?
Adrenalectomy
1
2014
34
0.120
Why?
Adrenal Glands
1
2014
39
0.120
Why?
Pheochromocytoma
1
2014
36
0.110
Why?
Adrenal Gland Neoplasms
1
2014
51
0.110
Why?
Female
6
2024
27053
0.110
Why?
Humans
7
2024
50419
0.100
Why?
Postoperative Complications
2
2022
1030
0.100
Why?
Survival Rate
2
2024
906
0.090
Why?
Follow-Up Studies
2
2024
2231
0.080
Why?
Flow Cytometry
1
2009
472
0.060
Why?
Mice, Knockout
1
2009
840
0.060
Why?
Parathyroidectomy
1
2024
46
0.060
Why?
Chemotherapy, Adjuvant
1
2024
119
0.060
Why?
Adult
3
2024
13561
0.050
Why?
Lymphatic Metastasis
1
2024
221
0.050
Why?
Middle Aged
3
2024
12579
0.050
Why?
Ileum
1
2022
85
0.050
Why?
Colon
1
2022
95
0.050
Why?
Insurance Coverage
1
2022
111
0.040
Why?
Aged
2
2024
9738
0.040
Why?
Prognosis
1
2024
1974
0.040
Why?
Prevalence
1
2022
967
0.040
Why?
Mice
1
2009
5659
0.040
Why?
Treatment Outcome
2
2022
5265
0.040
Why?
Healthcare Disparities
1
2022
280
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
997
0.040
Why?
Male
3
2024
25866
0.030
Why?
Israel
1
2014
9
0.030
Why?
Comparative Effectiveness Research
1
2014
44
0.030
Why?
Animals
1
2009
13063
0.030
Why?
Neoplasm Metastasis
1
2014
230
0.030
Why?
Reproducibility of Results
1
2014
1181
0.020
Why?
Halfteck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_